BRIEF published on 11/04/2025 at 14:18, 1 month ago MEDICLIN AG Reports Steady Growth in 2025 Sales Growth MEDICLIN AG Healthcare Services 2025 Financial Results Capacity Utilisation
PRESS RELEASE published on 11/04/2025 at 14:13, 1 month ago MEDICLIN on track: business development in line with expectations MEDICLIN AG reports strong financial performance with consolidated group sales of EUR 586.9 million in 9 months 2025, showing a 5.1% increase from last year. Group operating result amounts to EUR 48.9 million Financial Performance Operating Result MEDICLIN AG Consolidated Group Sales Annual Guidance
BRIEF published on 07/31/2025 at 13:18, 4 months 4 days ago MEDICLIN's First Half 2025 Interim Results Show Growth Financial Results Sales Growth Profit Forecast MEDICLIN AG Segment Performance
PRESS RELEASE published on 07/31/2025 at 13:13, 4 months 4 days ago MEDICLIN reports positive interim results for the first half of 2025 MEDICLIN reports positive interim results for the first half of 2025, with a significant increase in group operating result and sales. Stable capacity utilisation at 86.1% Sales MEDICLIN 2025 Interim Results Capacity Utilisation
BRIEF published on 06/04/2025 at 13:32, 6 months ago MEDICLIN AG: Majority Support at Annual General Meeting Financial Results Annual General Meeting MEDICLIN AG Healthcare Market Resolutions Approved
PRESS RELEASE published on 06/04/2025 at 13:27, 6 months ago MEDICLIN AG: Annual General Meeting approves all proposed resolutions MEDICLIN AG's Annual General Meeting approves all proposed resolutions on 4 June 2024. CEO highlights strong financial results amidst healthcare market changes Financial Results Annual General Meeting Resolutions MEDICLIN AG Healthcare Market
BRIEF published on 05/02/2025 at 13:03, 7 months 2 days ago MEDICLIN Reports Increased Operating Results for Q1 2025 Healthcare Sector Germany Q1 2025 Financials MEDICLIN AG Earnings Stable Sales
PRESS RELEASE published on 05/02/2025 at 12:58, 7 months 2 days ago MEDICLIN increases group operating result in the first quarter of 2025 MEDICLIN AG reports increased group operating result of EUR 5.2 mill. in Q1 2025 with stable sales and capacity utilisation. Details on segment performance included Sales MEDICLIN AG Q1 2025 Group Operating Result Capacity Utilisation
BRIEF published on 03/28/2025 at 10:29, 8 months 7 days ago MEDICLIN Concludes Profitable 2024 Financial Year Sales Growth Operating Result Future Outlook MEDICLIN AG 2024 Financial Results
PRESS RELEASE published on 03/28/2025 at 10:24, 8 months 7 days ago MEDICLIN ends successful 2024 financial year MEDICLIN AG successfully concludes its 2024 financial year with highest sales to date. Annual report highlights strategic focus on rehabilitation and future goals Sales Growth Annual Report Rehabilitation 2024 Financial Year MEDICLIN AG
Published on 12/05/2025 at 02:35, 2 hours 52 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 27 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 22 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 27 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 57 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 36 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 2 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 12 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 16 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 27 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 42 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 43 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 26 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
